U.S. pharma huge copyright scrapped two experimental weight loss supplements past 12 months—a the moment-day by day pill, lotiglipron, because of elevated liver enzymes plus a two times-day-to-day tablet, danuglipron, resulting from powerful Unwanted side effects—but CEO Albert Bourl